Providing innovative solutions for chronic wounds
amid growing antimicrobial resistance (AMR)
Ageing populations, diabetes and vascular disease are driving a growing wound burden across healthcare systems¹.
Biofilm and persistent microbial contamination can delay healing and complicate standard wound care pathways².
matoke’s RO platform is designed around antimicrobial activity without relying on conventional antibiotic mechanisms.
Specifically designed to tackle antimicrobial resistance through innovative therapeutic approaches.
See RO Technology
Silver-based wound dressings have long been a key tool in the management of chronic wounds; however, the FDA is proposing a new classification scheme for antimicrobial wound dressings based on AMR concern
Neil brings over 15 years of experience within the medical device and over the counter (OTC) healthcare sectors. His experience will be crucial as we develop our RO technology across several products in our pipeline.
